Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
Abstract Background Peripheral artery disease (PAD) is recognized as a significant predictor of mortality and adverse cardiovascular outcomes in patients with coronary heart disease (CHD). In fact, coexisting PAD and CHD is strongly associated with a greater coronary event recurrence compared with e...
Main Authors: | Elena M. Yubero-Serrano, Juan F. Alcalá-Diaz, Francisco M. Gutierrez-Mariscal, Antonio P. Arenas-de Larriva, Patricia J. Peña-Orihuela, Ruth Blanco-Rojo, Javier Martinez-Botas, Jose D. Torres-Peña, Pablo Perez-Martinez, Jose M. Ordovas, Javier Delgado-Lista, Diego Gómez-Coronado, Jose Lopez-Miranda |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-03-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-021-01260-3 |
Similar Items
-
Correction to: Association between cholesterol efflux capacity and peripheral artery disease in coronary heart disease patients with and without type 2 diabetes: from the CORDIOPREV study
by: Elena M. Yubero-Serrano, et al.
Published: (2021-04-01) -
HDL cholesterol efflux normalised to apoA-I is associated with future development of type 2 diabetes: from the CORDIOPREV trial
by: Ruth Blanco-Rojo, et al.
Published: (2017-10-01) -
Telomere Maintenance Is Associated with Type 2 Diabetes Remission in Response to a Long-Term Dietary Intervention without Non-Weight Loss in Patients with Coronary Heart Disease: From the CORDIOPREV Randomized Controlled Trial
by: Ana Ojeda-Rodriguez, et al.
Published: (2024-01-01) -
Telomere length as biomarker of nutritional therapy for prevention of type 2 diabetes mellitus development in patients with coronary heart disease: CORDIOPREV randomised controlled trial
by: Ana Ojeda-Rodriguez, et al.
Published: (2024-03-01) -
Trimethylamine Oxidation into the Proatherogenic Trimethylamine N-Oxide Is Higher in Coronary Heart Disease Men: From the CORDIOPREV Study
by: Helena Garcia-Fernandez, et al.
Published: (2025-01-01)